• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Silence Therapeutics plc

Headquarters: London, United Kingdom
Year Founded: 1999
Status: Public
Industry Sector: CommercialServices
CEO: Craig Allen Tooman, MBA
Number Of Employees: 116
Enterprise Value: $170,988,100
PE Ratio: -1.82
Exchange/Ticker 1: NASDAQ:SLN
Exchange/Ticker 2: N/A
Latest Market Cap: $144,035,296